Restructuring

A junior miner is raising cash not to dig, but to find a completely new business. This is a high-stakes gamble that signals a profound identity crisis.

The biotech has gone all-in on its lead drug, bel-sar, cutting 20% of staff and shelving a promising bladder cancer program to secure its financial future.

Amidst declining revenue and layoffs, Rapid7's new CEO is making a bold bet on a focused, AI-driven strategy. Is this the path to renewed strength?

Miami-based Gencom restructures into two distinct units, sharpening its focus on investment and execution to scale its $8 billion luxury real estate empire.

The work management giant posted strong Q2 results but is betting its future on a radical AI pivot, cutting staff to fund a new era of automated execution.

HeartCore Enterprises sells its Vietnamese software venture for a modest sum, signaling a major strategic shift to its high-stakes IPO consulting business.

With Oaktree's long chapter closed, asset manager Brookfield is now the ultimate power behind a key TORM shareholder. What does this shift mean for the tanker giant?

Amid falling earnings and regulatory battles, Algonquin Power & Utilities is redomiciling to the U.S. A look at the strategy behind the corporate shift.

electroCore posts strong Q2 growth and raises guidance, driven by a federal market focus. But as the company maps a path to profitability, a closer look reveals a race between strategic execution and a dwindling cash runway.

As Intchains prepares its H1 2026 report, it's not just financials on the line. It's a test of a bold strategy to build a Web3 ecosystem beyond Bitcoin.

A shocking $31M loss forces ethical egg purveyor Vital Farms into a defensive crouch, testing if brand loyalty can survive a brutal market oversupply.

Eagle Nuclear Energy's new auditor appointment is more than a routine update; it's a critical response to serious financial warnings, a move to stabilize its foundation as it builds a new US nuclear supply chain.

Facing steep losses and a delisting threat, luxury furniture giant Natuzzi is shrinking its Italian footprint and betting on a new generation of leadership.

Facing the biotech cash crunch, Context Therapeutics shelves one drug to double down on two others, a strategic pivot that secures its future into late 2027.

Traeger's revenue is down 17%, but its new Lowe's deal and aggressive cost-cutting signal a bold, risky pivot. Is this the right recipe for growth?

With a new $345 genome and major clinical wins, PacBio pushes boundaries. But can its strategic restructuring and bold R&D overcome mounting financial losses?

DOOR (formerly Latch) cuts a third of its staff, citing AI efficiency. The move highlights a harsh new reality in proptech, balancing innovation with survival.

The fast-growing home remodeler taps a cross-industry veteran as CTO, signaling an aggressive push to scale its AI platform and disrupt a legacy market.

As Perigon Wealth Management surpasses $11B in assets, a major leadership restructure centralizes operations under a dual COO/CIO to future-proof its expansion.

iBase-t is moving beyond software sales, launching a Value Realization team to embed operational experts and quantitative ROI accountability on the shop floor.